Drug developer ADARx seeks $1.74 billion valuation in US IPO
finance.yahoo.com
21.09.2026 19:00
45 views
Related stories
Alstom shares tumble 26% after train maker cuts profit forecast
ft.com · 02.11
Marine sniper turned macro strategist says this bull market has six to 12 months left. Here’s his playbook.
marketwatch.com · 02.11
Unpicking Microsoft’s free cash flow
ft.com · 02.11
Christmas donations gift demand up, charities say
bbc.co.uk · 02.11
Christmas shoebox appeal launches to help children
bbc.co.uk · 02.11
What data centre construction delays mean for debt holders
ft.com · 02.11